V. Arciero

发表

PGC1α curtails prostate cancer metastasis via metabolic rewiring

U. Emmenegger, E. McDonald, V. Arciero, 2016 .

Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group

A. Denburg, E. Lungu, C. Chambers, 2021, Current oncology.

Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis

Kelvin K. W. Chan, M. Raphael, A. Parmar, 2022, Journal of Cancer Research and Clinical Oncology.

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer

Kelvin K. W. Chan, J. Biagi, M. Raphael, 2022, JNCI cancer spectrum.

Reassessing the Net Benefit of Cancer Drugs With Evolution of Evidence Using the ASCO Value Framework.

Kelvin K. W. Chan, B. Gyawali, M. Cheung, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome

Liying Zhang, N. Fleshner, A. Kapoor, 2019, Cancer management and research.

Examining Trends in Cost and Clinical Benefit of Novel Anticancer Drugs Over Time.

Kelvin K. W. Chan, M. Cheung, W. Wong, 2018, Journal of oncology practice.

Assessment of Food and Drug Administration– and European Medicines Agency–Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life

Kelvin K. W. Chan, A. Parmar, R. Saluja, 2021, JAMA network open.

Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?

Kelvin K. W. Chan, M. Cheung, A. Chambers, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Do older and younger patients derive similar survival benefits from novel oncology drugs? A systematic review and meta-analysis

Kelvin K. W. Chan, R. Saluja, E. McDonald, 2018, Age and ageing.

Pembrolizumab Alone or with Chemotherapy for Metastatic Non-Small-Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.

N. Leighl, M. Doherty, A. Parmar, 2022, Critical reviews in oncology/hematology.

Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?

N. Leighl, M. Cheung, Doreen Ezeife, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis

Kelvin K. W. Chan, M. Raphael, A. Parmar, 2022, Journal of Cancer Research and Clinical Oncology.

Population-Based Analysis Of The Use Of Radium-223 For Bone-Metastatic Castration-Resistant Prostate Cancer In Ontario, And Of Factors Associated With Treatment Completion And Outcome

Liying Zhang, N. Fleshner, R. Chow, 2019 .